G'day Ahjay and all Immutep 'Lag(3)gards',
Yervov - CTLA-4 is thought to regulate T-cell proliferation early in an immune response, primarily in lymph nodes, whereas PD-1 suppresses T cells later in an immune response, primarily in peripheral tissues.
Opdivo - PD-1 (Nivolumab) is a targeted therapy. It is a human programmed death receptor-1 (PD-1) blocking antibody.
Efti - LAG-3 - MHC class II agonist eftilagimod alpha (efti, IMP321 or LAG-3Ig) is a soluble LAG-3 protein that activates APC leading to CD8 T-cell activation.
LAG-3 and PD-1 have synergistic benefits. 'Pressing the gas and releasing the brakes' analogy.
Although programmed death-ligand 1 (PD-L1) antibody–based therapy has improved the outcome of patients with
cancer, acquired resistance to these treatments limits their clinical efficacy. LAG-3 and PD-L1 with the potential to reinvigorate exhausted immune cells and overcome resistance mechanisms to PD-L1 blockade.
Therefore reason efti combo patent application not registered with Yervoy (or any CTLA-4 compound)
- Forums
- ASX - By Stock
- IMM
- Ann: TACTI-002 & INSIGHT-004 data to be presented at ASCO
Ann: TACTI-002 & INSIGHT-004 data to be presented at ASCO, page-45
-
- There are more pages in this discussion • 216 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add IMM (ASX) to my watchlist
|
|||||
Last
39.0¢ |
Change
-0.010(2.50%) |
Mkt cap ! $566.5M |
Open | High | Low | Value | Volume |
39.0¢ | 39.5¢ | 38.5¢ | $997.5K | 2.559M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
4 | 85852 | 38.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
39.0¢ | 75389 | 4 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 82255 | 0.385 |
9 | 274350 | 0.380 |
3 | 35464 | 0.375 |
5 | 94020 | 0.370 |
2 | 11078 | 0.365 |
Price($) | Vol. | No. |
---|---|---|
0.390 | 75389 | 4 |
0.395 | 44264 | 2 |
0.400 | 176281 | 6 |
0.405 | 187434 | 3 |
0.410 | 296117 | 10 |
Last trade - 16.10pm 04/09/2024 (20 minute delay) ? |
Featured News
IMM (ASX) Chart |